Inventor · disambiguated record
Kenneth Jeff Thrasher
Also filed as: THRASHER KENNETH J · THRASHER KENNETH JEFF
29 granted patents·1 pending application·107 citations·filing 1995–2015
95Inventor score
Top patents by PatentIndex Score
30 records- 0181US6639076B1Growth hormone secretagoguesLILLY CO ELI·Filed 1999·Granted Oct 28, 2003·25 cites·19 claims
- 0278US7947841B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2008·Granted May 24, 2011·2 cites·15 claims
- 0378US7662771B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2004·Granted Feb 16, 2010·7 cites·10 claims
- 0471US6743794B2Methods and compounds for inhibiting MRP1LILLY CO ELI·Filed 2000·Granted Jun 1, 2004·7 cites·39 claims
- 0568US8546581B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptideJUNGHEIM LOUIS NICKOLAUS·Filed 2011·Granted Oct 1, 2013·1 cites·13 claims
- 0667US8765796B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2013·Granted Jul 1, 2014·0 cites·12 claims
- 0767US8552039B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptideHERR ROBERT JASON·Filed 2009·Granted Oct 8, 2013·1 cites·14 claims
- 0867US6413991B1Selective β3 adrenergic agonistsLILLY CO ELI·Filed 2000·Granted Jul 2, 2002·2 cites·30 claims
- 0967US6140352ACarbazolyl-substituted ethanolamines as selective β-3 agonistsLILLY CO ELI·Filed 1997·Granted Oct 31, 2000·18 cites·41 claims
- 1062US5710285AProcess for preparing 2-substituted benzo B!thiophene compounds and intermediates thereofLILLY CO ELI·Filed 1995·Granted Jan 20, 1998·6 cites·8 claims
- 1159US6992097B2Growth hormone secretagoguesLILLY CO ELI·Filed 2003·Granted Jan 31, 2006·1 cites·15 claims
- 1255US2007293423A1Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist PeptideLILLY CO ELI·Filed 2004·Application pending·0 cites
- 1354US6075151ABenzothiophene compounds, intermediates, processes, compositions, and methodsLILLY CO ELI·Filed 1998·Granted Jun 13, 2000·9 cites·8 claims
- 1453US6686372B2Selective β3 adrenergic agonistsLILLY CO ELI·Filed 2002·Granted Feb 3, 2004·0 cites·17 claims
- 1552US5843963ABenzothiophene compounds, intermediates, processes, compositions, and methodsLILLY CO ELI·Filed 1997·Granted Dec 1, 1998·8 cites·13 claims
- 1647US6087378APharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndromeLILLY CO ELI·Filed 1999·Granted Jul 11, 2000·5 cites·35 claims
- 1744US6350884B1Acrylic and propionic acid compounds, intermediates, processes, compositions, and methodLILLY CO ELI·Filed 1997·Granted Feb 26, 2002·2 cites·6 claims
- 1843US7037921B2Compounds and methods for inhibiting MRP1LILLY CO ELI·Filed 2002·Granted May 2, 2006·0 cites·10 claims
- 1941US7101891B2Compounds and pharmaceutical compositions for inhibiting MRP1LILLY CO ELI·Filed 2002·Granted Sep 5, 2006·0 cites·2 claims
- 2041US6265575B1Antithrombotic diaminesLILLY CO ELI·Filed 1999·Granted Jul 24, 2001·4 cites·2 claims
- 2140US6440958B1Acrylic and propionic acid compounds, intermediates, processes, compositions, and methodsLILLY CO ELI·Filed 1996·Granted Aug 27, 2002·3 cites·20 claims
- 2240US5614639AProcess for preparing 2-substituted benzo[b]thiophene compounds and intermediates thereofLILLY CO ELI·Filed 1995·Granted Mar 25, 1997·1 cites·25 claims
- 2338US7125840B2Substituted dipeptides as growth hormone secretagoguesLILLY CO ELI·Filed 2001·Granted Oct 24, 2006·0 cites·44 claims
- 2437US9776992B21-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancersLILLY CO ELI·Filed 2015·Granted Oct 3, 2017·0 cites·8 claims
- 2537US5856339ABenzothiophene compounds, intermediates, compositions, and methodsLILLY CO ELI·Filed 1995·Granted Jan 5, 1999·2 cites·12 claims
- 2636US6258826B1Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndromeLILLY CO ELI·Filed 1999·Granted Jul 10, 2001·1 cites·24 claims
- 2735US5986109ABenzothiophene compounds, intermediates, compositions, and methodsLILLY CO ELI·Filed 1998·Granted Nov 16, 1999·1 cites·6 claims
- 2835US5981765ABenzothiophene compounds, intermediates, compositions, and methodsLILLY CO ELI·Filed 1998·Granted Nov 9, 1999·1 cites·28 claims
- 2935US5969142ABenzothiophene compounds, intermediates, compositions and methodsLILLY CO ELI·Filed 1997·Granted Oct 19, 1999·0 cites·3 claims
- 3034US5712390AProcess for preparing 2-substituted benzo B! Thiophene compounds and intermediates thereofLILLY CO ELI·Filed 1995·Granted Jan 27, 1998·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Kenneth Jeff Thrasher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →